Orchard Therapeutics' Corporate Minority Round

Orchard Therapeutics raised a round of funding on April 12, 2018. Investors include GlaxoSmithKline.

Orchard Therapeutics is a biotechnology company focused on the development and commercialization of transformative ex-vivo gene therapies for patients with orphan diseases. Orchard's development progr…

Articles about Orchard Therapeutics' Corporate Minority Round: